• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌女性患者血清游离/总前列腺特异性抗原比值具有预后意义。

Free/Total Serum Prostate-Specific Antigen Ratio in Women with Colorectal Cancer Has Prognostic Significance.

作者信息

Duraker Nüvit, Çaynak Zeynep Civelek, Trabulus Didem Can

机构信息

Department of Surgery, SB Okmeydanı Training and Research Hospital, İstanbul, Turkey.

Department of Surgery, Bayındır Levent Hospital, İstanbul, Turkey.

出版信息

J Gastrointest Cancer. 2017 Mar;48(1):8-12. doi: 10.1007/s12029-016-9859-8.

DOI:10.1007/s12029-016-9859-8
PMID:27447478
Abstract

PURPOSE

The presence of prostate-specific antigen (PSA) in colon cancer tissues has been shown, but its clinical significance has not been known yet in colorectal cancer patients. We investigated the prognostic significance of percent free PSA value (free PSA/total PSA × 100) in female patients with colorectal cancer.

METHODS

The serum concentrations of total and free PSA were measured by solid-phase two-site immunoradiometric assay in 184 patients.

RESULTS

The cancer-specific survival (CSS) of patients with percent free PSA value ≥35 was significantly better compared to that of patients with percent free PSA value <35 (CSS rate was 82.9 and 55.5 %, respectively; log-rank x = 8135, p = 0.004). In multivariate Cox analysis, this percent free PSA threshold value had independent prognostic significance (relative risk 0.27, 95 % confidence interval 0.11-0.64, p = 0.003).

CONCLUSION

Percent free PSA value, calculated by serum total and free PSA levels, has prognostic significance in women with colorectal cancer. The studies with larger patient series, utilizing ultrasensitive PSA assays whose lowest detection limit is lower, are required for a clearer understanding of this issue.

摘要

目的

已证实在结肠癌组织中存在前列腺特异性抗原(PSA),但其在结直肠癌患者中的临床意义尚不清楚。我们研究了游离PSA值百分比(游离PSA/总PSA×100)在女性结直肠癌患者中的预后意义。

方法

采用固相双位点免疫放射分析法测定了184例患者血清中总PSA和游离PSA的浓度。

结果

游离PSA值百分比≥35%的患者的癌症特异性生存率(CSS)显著优于游离PSA值百分比<35%的患者(CSS率分别为82.9%和55.5%;对数秩检验χ² = 8.135,p = 0.004)。在多因素Cox分析中,该游离PSA百分比阈值具有独立的预后意义(相对风险0.27,95%置信区间0.11 - 0.64,p = 0.003)。

结论

通过血清总PSA和游离PSA水平计算得出的游离PSA值百分比在女性结直肠癌患者中具有预后意义。为更清楚地了解这一问题,需要开展更大样本量患者的研究,并采用最低检测限更低的超灵敏PSA检测方法。

相似文献

1
Free/Total Serum Prostate-Specific Antigen Ratio in Women with Colorectal Cancer Has Prognostic Significance.结直肠癌女性患者血清游离/总前列腺特异性抗原比值具有预后意义。
J Gastrointest Cancer. 2017 Mar;48(1):8-12. doi: 10.1007/s12029-016-9859-8.
2
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer.不同形式的前列腺特异性抗原及其比值在前列腺癌患者中的预后价值。
BJU Int. 1999 Dec;84(9):1021-7. doi: 10.1046/j.1464-410x.1999.00345.x.
3
Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.对于高风险或极高风险前列腺癌患者,在接受放射治疗后达到前列腺特异性抗原无法检测水平时接受辅助雄激素剥夺治疗的患者预后良好。
PLoS One. 2021 Mar 12;16(3):e0248461. doi: 10.1371/journal.pone.0248461. eCollection 2021.
4
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.人腺体激肽释放酶的重要性及其在前列腺癌检测中与不同前列腺特异性抗原血清形式的相关性。
Cancer. 1998 Dec 15;83(12):2540-7.
5
Association between percent-free prostate-specific antigen and glomerular filtration rate in transrectal ultrasound-guided biopsy-proven patients with prostate-specific antigen levels ranging from 4 to 10 ng/ml.在经直肠超声引导下前列腺特异性抗原水平为 4 至 10ng/ml 的前列腺穿刺活检确诊患者中,游离前列腺特异性抗原百分比与肾小球滤过率之间的相关性。
World J Urol. 2013 Apr;31(2):313-8. doi: 10.1007/s00345-012-1012-0. Epub 2013 Jan 3.
6
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases.通过前列腺特异性抗原增加的数学模型识别前列腺癌患者中侵袭性最强的癌。
Clin Genitourin Cancer. 2016 Jun;14(3):210-217.e1. doi: 10.1016/j.clgc.2015.12.006. Epub 2015 Dec 18.
7
Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.三个月时的前列腺特异性抗原水平作为雄激素剥夺治疗联合放疗治疗中高危前列腺癌患者的治疗反应的生物标志物。
Cancer. 2018 Jul 15;124(14):2939-2947. doi: 10.1002/cncr.31400. Epub 2018 May 4.
8
[The percentage of free prostate specific antigen used in detecting prostate cancer].[游离前列腺特异性抗原在前列腺癌检测中的应用百分比]
Zhonghua Wai Ke Za Zhi. 1999 Jan;37(1):47-9.
9
Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy.根治性前列腺切除术后无法检测到超敏前列腺特异性抗原最低值的预后意义。
Urology. 2010 Sep;76(3):723-7. doi: 10.1016/j.urology.2010.03.081. Epub 2010 Jul 1.
10
Serum prostate-specific antigen value adjusted for non-cancerous prostate tissue volume in patients undergoing radical prostatectomy: a new predictor of biochemical recurrence in localized or locally advanced prostate cancer.根治性前列腺切除术后按非癌前列腺组织体积校正的血清前列腺特异性抗原值:局部或局部进展性前列腺癌生化复发的新预测因子。
Asian J Androl. 2011 Mar;13(2):248-53. doi: 10.1038/aja.2010.152. Epub 2010 Nov 22.

引用本文的文献

1
Expression of anoctamin 7 (ANO7) is associated with poor prognosis and mucin 2 (MUC2) in colon adenocarcinoma: a study based on TCGA data.anoctamin 7(ANO7)的表达与结肠腺癌的不良预后及黏蛋白2(MUC2)相关:一项基于TCGA数据的研究
Genomics Inform. 2023 Dec;21(4):e46. doi: 10.5808/gi.23071. Epub 2023 Dec 29.
2
The most effective but largely ignored target for prostate cancer early detection and intervention.前列腺癌早期检测和干预最有效但在很大程度上被忽视的靶点。
J Cancer. 2022 Oct 17;13(13):3463-3475. doi: 10.7150/jca.72973. eCollection 2022.
3
Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.

本文引用的文献

1
Reconnoitring the status of prostate specific antigen and its role in women.探究前列腺特异性抗原在女性中的状况及其作用。
Indian J Clin Biochem. 2015 Apr;30(2):124-33. doi: 10.1007/s12291-014-0451-3. Epub 2014 Jun 22.
2
Is Serum Prostate-specific Antigen a Diagnostic Marker for Benign and Malignant Breast Tumors in Women?血清前列腺特异性抗原是女性良性和恶性乳腺肿瘤的诊断标志物吗?
Int J Prev Med. 2015 Feb 20;6:15. doi: 10.4103/2008-7802.151824. eCollection 2015.
3
Serum level of prostate-specific antigen (PSA) in women with breast cancer.
血浆DNA完整性作为结直肠癌化疗的预后生物标志物
J Oncol. 2021 May 26;2021:5569783. doi: 10.1155/2021/5569783. eCollection 2021.
女性乳腺癌患者的前列腺特异性抗原(PSA)血清水平。
Cancer Epidemiol. 2013 Oct;37(5):613-8. doi: 10.1016/j.canep.2013.06.009. Epub 2013 Aug 8.
4
The lady with raised prostate specific antigen: do we need to worry?前列腺特异性抗原升高的女性:我们需要担心吗?
Asian Pac J Cancer Prev. 2011;12(8):2051-3.
5
Prostate-specific antigen in the serum of women with benign breast disease.患有良性乳腺疾病女性血清中的前列腺特异性抗原。
Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):212-6. doi: 10.1016/j.ejogrb.2007.05.023. Epub 2007 Sep 11.
6
Expression of prostate-specific membrane antigen in normal and malignant human tissues.
World J Surg. 2006 Apr;30(4):628-36. doi: 10.1007/s00268-005-0544-5.
7
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.结肠癌患者中前列腺特异性抗原反应性细胞毒性T淋巴细胞前体
Oncol Rep. 2006 Feb;15(2):317-21.
8
Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma.结直肠癌女性患者血清总前列腺特异性抗原和游离前列腺特异性抗原的检测
Br J Cancer. 2002 Jan 21;86(2):203-6. doi: 10.1038/sj.bjc.6600049.
9
Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.患有良性乳腺疾病或乳腺癌的女性血清中的超敏前列腺特异性抗原(PSA)
Anticancer Res. 2000 May-Jun;20(3B):2151-4.
10
Serum total and free prostate-specific antigen for breast cancer diagnosis in women.血清总前列腺特异性抗原和游离前列腺特异性抗原用于女性乳腺癌诊断
Clin Cancer Res. 2000 Feb;6(2):467-73.